![Kai Pinkernell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kai Pinkernell
Amministratore Delegato presso Dr. Falk Pharma GmbH
Profilo
Kai Pinkernell is currently the Co-Managing Director at Dr. Falk Pharma GmbH.
Previously, he held the position of Senior Director-Regenerative Cell Technology at Plus Therapeutics, Inc. He also served as the Chief Medical Officer & Senior Vice President at MediGene AG.
Prior to that, he was the Head-Global Clinical Business at Miltenyi GmbH from 2012 to 2016.
Dr. Pinkernell holds a doctorate degree from the University of Münster and an MBA from USC Marshall School of Business.
Posizioni attive di Kai Pinkernell
Società | Posizione | Inizio |
---|---|---|
Dr. Falk Pharma GmbH
![]() Dr. Falk Pharma GmbH Medical/Nursing ServicesHealth Services Dr. Falk Pharma GmbH engages in the development and sale of medication for indications in hematology and gastroenterology in Germany and internationally. The company principally offers prescription drugs that are used in treating inflammatory bowel diseases, cholestatic liver diseases, irritable bowel syndromes, and constipation, as well as for colon cleansing prior to colonoscopies. It also organizes and sponsors medical education events; and offers publications for healthcare professionals, as well as for patients and their families. The company was formerly known as Dr. Falk Arzneimittel GmbH & Co KG and changed its name to Dr. Falk Pharma GmbH in 1989. Dr. Falk Pharma GmbH was founded in 1960 and is headquartered in Freiburg, Germany | Amministratore Delegato | - |
Precedenti posizioni note di Kai Pinkernell
Società | Posizione | Fine |
---|---|---|
Miltenyi GmbH
![]() Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Corporate Officer/Principal | 01/01/2016 |
MEDIGENE AG | Direttore Tecnico/Scientifico/R&S | - |
PLUS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Kai Pinkernell
University of Münster | Doctorate Degree |
USC Marshall School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
MEDIGENE AG | Health Technology |
PLUS THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Miltenyi GmbH
![]() Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Finance |
Dr. Falk Pharma GmbH
![]() Dr. Falk Pharma GmbH Medical/Nursing ServicesHealth Services Dr. Falk Pharma GmbH engages in the development and sale of medication for indications in hematology and gastroenterology in Germany and internationally. The company principally offers prescription drugs that are used in treating inflammatory bowel diseases, cholestatic liver diseases, irritable bowel syndromes, and constipation, as well as for colon cleansing prior to colonoscopies. It also organizes and sponsors medical education events; and offers publications for healthcare professionals, as well as for patients and their families. The company was formerly known as Dr. Falk Arzneimittel GmbH & Co KG and changed its name to Dr. Falk Pharma GmbH in 1989. Dr. Falk Pharma GmbH was founded in 1960 and is headquartered in Freiburg, Germany | Health Services |
- Borsa valori
- Insiders
- Kai Pinkernell